BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Brain cancer

1. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. OLIG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. KIAA1549
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. H3F3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. HIST1H3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. TRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. EIF3E
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. GRIN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. MAP2K4
    [